Expertise in
17
conditions

Dr. Alan C. Hartford

Radiation Oncology
Fresenius Medical Care St Johnsbury
1080 Hospital Dr, 
Saint Johnsbury, VT 
Clinical Trials:Currently Recruiting for 1 Trial
Expertise in
17
conditions
Fresenius Medical Care St Johnsbury
1080 Hospital Dr, 
Saint Johnsbury, VT 

Overview

Alan Hartford is a Radiation Oncologist practicing medicine in Saint Johnsbury, Vermont.

Dr. Hartford is highly rated in 17 conditions, according to our data. His clinical expertise encompasses Prostate Cancer, Familial Prostate Cancer, Posterior Fossa Tumor, Astrocytoma, and Gastrostomy.

He is actively involved in clinical research, co-authoring 50 peer reviewed articles and participating in 17 clinical trials.

Specialties

Radiation Oncology

Licenses

Radiology in MA

Hospital Affiliations

Umass Memorial Medical Center/university Campus
Umass Memorial Healthalliance Hospitals
Heywood Hospital -

Languages Spoken

English

Gender

Male

Insurance

Accepted insurance can change. Please verify directly with the provider.

Find your insurance
Find your insuranceClose

Accepted insurance plans:

Aetna
  • EPO
  • HMO
  • POS
  • PPO
Anthem BCBS
  • EPO
  • HMO
  • POS
  • PPO
Blue Cross Blue Shield
  • EPO
  • HMO
  • POS
  • PPO
Commonwealth Care Alliance
  • MANAGED MEDICAID PLAN
  • MEDICARE MAPD
  • MEDICARE PDP
  • MEDICARE SNP
  • MEDICARE-MEDICAID PLAN
Humana
  • HMO
  • INDEMNITY
  • POS
  • PPO
UnitedHealthcare
  • EPO
  • HMO
  • POS
  • PPO
Wellcare
  • EPO
  • HMO
  • INSURANCE PLAN
  • MANAGED MEDICAID PLAN
  • MEDICARE MAPD
  • MEDICARE PDP
  • MEDICARE SNP
  • MEDICARE-MEDICAID PLAN
  • OTHER MEDICARE
  • OTHER MEDICARE PART D
View 2 Less Insurance Carriers -

Locations

Fresenius Medical Care St Johnsbury
1080 Hospital Dr, Saint Johnsbury, VT 05819
Other Locations
Mary Hitchcock Memorial Hospital
1 Medical Center Dr, Lebanon, NH 03756

Clinical Research

Clinical research consists of overseeing clinical studies of patients undergoing new treatments and therapies, and publishing articles in peer reviewed medical journals. Providers who actively participate in clinical research are generally at the forefront of the fields and aware of the most up-to-date advances in treatments for their patients.

17 Clinical Trials

Phase III Trial of Observation Versus Irradiation for a Gross Totally Resected Grade II Meningioma
Phase III Trial of Observation Versus Irradiation for a Gross Totally Resected Grade II Meningioma
Enrollment Status: Recruiting
Publish Date: June 25, 2026
Intervention Type: Other, Procedure, Radiation
Study Phase: Phase 3
Randomized Phase II Trial of Hypofractionated Dose-Escalated Photon IMRT or Proton Beam Therapy Versus Conventional Photon Irradiation With Concomitant and Adjuvant Temozolomide in Patients With Newly Diagnosed Glioblastoma
Randomized Phase II Trial of Hypofractionated Dose-Escalated Photon IMRT or Proton Beam Therapy Versus Conventional Photon Irradiation With Concomitant and Adjuvant Temozolomide in Patients With Newly Diagnosed Glioblastoma
Enrollment Status: Active_not_recruiting
Publish Date: August 28, 2026
Intervention Type: Radiation, Drug
Study Drug: Temozolomide
Study Phase: Phase 2
Phase III Randomized Trial of Concurrent Chemoradiotherapy With or Without Atezolizumab in Localized Muscle Invasive Bladder Cancer
Phase III Randomized Trial of Concurrent Chemoradiotherapy With or Without Atezolizumab in Localized Muscle Invasive Bladder Cancer
Enrollment Status: Active_not_recruiting
Publish Date: August 28, 2026
Intervention Type: Other, Procedure, Drug, Radiation
Study Drugs: Atezolizumab, Cisplatin, Fluorouracil, Gemcitabine, Mitomycin C
Study Phase: Phase 3
A Phase II, Double-Blinded, Placebo-Controlled Randomized Trial of Salvage Radiotherapy With or Without Enhanced Anti-Androgen Therapy With Apalutamide in Recurrent Prostate Cancer (BALANCE*)
A Phase II, Double-Blinded, Placebo-Controlled Randomized Trial of Salvage Radiotherapy With or Without Enhanced Anti-Androgen Therapy With Apalutamide in Recurrent Prostate Cancer (BALANCE*)
Enrollment Status: Active_not_recruiting
Publish Date: August 28, 2026
Intervention Type: Other, Radiation, Drug
Study Drug: Apalutamide
Study Phase: Phase 2
Parallel Phase III Randomized Trials for High Risk Prostate Cancer Evaluating De-Intensification for Lower Genomic Risk and Intensification of Concurrent Therapy for Higher Genomic Risk With Radiation (PREDICT-RT*)
Parallel Phase III Randomized Trials for High Risk Prostate Cancer Evaluating De-Intensification for Lower Genomic Risk and Intensification of Concurrent Therapy for Higher Genomic Risk With Radiation (PREDICT-RT*)
Enrollment Status: Active_not_recruiting
Publish Date: August 17, 2026
Intervention Type: Drug, Procedure, Other, Radiation
Study Drugs: Abiraterone acetate, Apalutamide, Bicalutamide, Buserelin, Degarelix, Flutamide, Goserelin, Histrelin, Leuprolide, Prednisone, Triptorelin
Study Phase: Phase 3
Randomized Phase III Study of Focal Radiation Therapy for Unresectable, Localized Intrahepatic Cholangiocarcinoma
Randomized Phase III Study of Focal Radiation Therapy for Unresectable, Localized Intrahepatic Cholangiocarcinoma
Enrollment Status: Terminated
Publish Date: July 13, 2026
Intervention Type: Radiation
Study Phase: Phase 3
A Randomized Phase III Trial of Hypofractionated Post-Prostatectomy Radiation Therapy (HYPORT) Versus Conventional Post-Prostatectomy Radiation Therapy (COPORT)
A Randomized Phase III Trial of Hypofractionated Post-Prostatectomy Radiation Therapy (HYPORT) Versus Conventional Post-Prostatectomy Radiation Therapy (COPORT)
Enrollment Status: Completed
Publish Date: July 09, 2026
Intervention Type: Other, Radiation
Study Phase: Phase 3
Phase II-III Trial of Adjuvant Radiotherapy and Androgen Deprivation Following Radical Prostatectomy With or Without Adjuvant Docetaxel
Phase II-III Trial of Adjuvant Radiotherapy and Androgen Deprivation Following Radical Prostatectomy With or Without Adjuvant Docetaxel
Enrollment Status: Completed
Publish Date: June 25, 2026
Intervention Type: Drug, Other, Radiation
Study Drugs: Bicalutamide, Docetaxel, Flutamide, Goserelin acetate, Leuprolide acetate, Nilutamide
Study Phase: Phase 2/Phase 3
A Randomized Phase II Trial for Patients With p16 Positive, Non-Smoking Associated, Locoregionally Advanced Oropharyngeal Cancer
A Randomized Phase II Trial for Patients With p16 Positive, Non-Smoking Associated, Locoregionally Advanced Oropharyngeal Cancer
Enrollment Status: Completed
Publish Date: May 22, 2026
Intervention Type: Drug, Radiation
Study Drug: Cisplatin
Study Phase: Phase 2
Randomized Phase II Trial of Postoperative Adjuvant IMRT Following Cystectomy for pT3/T4 Urothelial Bladder Cancer
Randomized Phase II Trial of Postoperative Adjuvant IMRT Following Cystectomy for pT3/T4 Urothelial Bladder Cancer
Enrollment Status: Terminated
Publish Date: May 22, 2026
Intervention Type: Radiation
Study Phase: Phase 2
View 9 Less Clinical Trials

50 Total Publications

Trust: A Lesson in Truth.
Trust: A Lesson in Truth.
Journal: Practical radiation oncology
Published: October 21, 2025
Similar Doctors
Expertise in
24
conditions
Dr. Thomas F. Delaney
Radiation Oncology
Expertise in
24
conditions
Dr. Thomas F. Delaney
Radiation Oncology
Referral may be required

Mary Hitchcock Memorial Hospital

1 Medical Center Dr, 
Lebanon, NH 
 (54.5 miles away)
Experience:
44+ years
Languages Spoken:
English
See accepted insurances
Accepting New Patients
Offers Telehealth

Thomas Delaney is a Radiation Oncologist practicing medicine in Lebanon, New Hampshire. He has been practicing medicine for over 44 years. Dr. Delaney is highly rated in 24 conditions, according to our data. His clinical expertise encompasses Adult Soft Tissue Sarcoma, Chordoma, Bone Tumor, Liposarcoma, and Pancreaticoduodenectomy. Dr. Delaney is currently accepting new patients.

Expertise in
25
conditions
Dr. Gregory A. Russo
Radiation Oncology
Expertise in
25
conditions
Dr. Gregory A. Russo
Radiation Oncology
Referral may be required

Northeastern Vermont Regional Hospital

1315 Hospital Dr, 
Saint Johnsbury, VT 
 (0.2 miles away)
Languages Spoken:
English
See accepted insurances
Accepting New Patients
Offers Telehealth

Gregory Russo is a Radiation Oncologist practicing medicine in Saint Johnsbury, Vermont. Dr. Russo is highly rated in 25 conditions, according to our data. His clinical expertise encompasses Posterior Fossa Tumor, Primitive Neuroectodermal Tumor (PNET), Lung Cancer, Pleuropulmonary Blastoma, and Pancreaticoduodenectomy. Dr. Russo is currently accepting new patients.

Expertise in
10
conditions
Dr. Lesley A. Jarvis
Radiation Oncology
Expertise in
10
conditions
Dr. Lesley A. Jarvis
Radiation Oncology
Referral may be required

Fresenius Medical Care St Johnsbury

1080 Hospital Dr, 
Saint Johnsbury, VT 
 (0.1 miles away)
Languages Spoken:
English
See accepted insurances
Offers Telehealth

Lesley Jarvis is a Radiation Oncologist practicing medicine in Saint Johnsbury, Vermont. Dr. Jarvis is highly rated in 10 conditions, according to our data. Her clinical expertise encompasses Breast Cancer, Posterior Fossa Tumor, Primitive Neuroectodermal Tumor (PNET), and Cutaneous T-Cell Lymphoma (CTCL).

Frequently Asked Questions about Dr. Alan C. Hartford

How do I make an appointment with Dr. Alan C. Hartford?

You can book an appointment with Dr. Alan C. Hartford by calling their office at 603-650-6600. MediFind provides direct contact information so you can schedule visits, second opinions, or consultations without navigating third-party calendars.

Is Dr. Alan C. Hartford a top-rated expert for Prostate Cancer?

MediFind is an objective health platform that identifies experts based on real-world data. Dr. Alan C. Hartford is classified as an Distinguished expert for Prostate Cancer, meaning they are among the top experts in the country for this condition. This ranking is based on their volume of patients, published research, and peer connections.

What conditions does Dr. Alan C. Hartford specialize in?

While Dr. Alan C. Hartford is a Radiation Oncology, they have specific expertise in Prostate Cancer, Familial Prostate Cancer, and Posterior Fossa Tumor. MediFind analyzes a doctor's articles and referral patterns to identify their specific areas of focus within Radiation Oncology.

Does Dr. Alan C. Hartford participate in research or clinical trials?

Yes. Dr. Alan C. Hartford has published 50 articles and abstracts on conditions like Prostate Cancer. You can view a list of Dr. Alan C. Hartford's latest peer-reviewed publications and clinical trial participation on their profile to see if they are active in new treatments.

Does Dr. Alan C. Hartford accept my insurance?

Dr. Alan C. Hartford accepts most major insurance plans, including Aetna and Anthem BCBS. We recommend calling the office directly at 603-650-6600 to verify that your specific plan is currently accepted before your visit.

Areas of Expertise

MediFind evaluates expertise by pulling from factors such as number of articles a doctor has published in medical journals, participation in clinical trials, speaking at industry conferences, prescribing and referral patterns, and strength of connections with other experts in their field.

Learn more about MediFind’s expert tiers

Find Dr. Hartford's expertise for a condition
ConditionClose
    View All 14 Advanced Conditions
    View All 50 Experienced Conditions
    Want to save this doctor for later?
    Sign Up
    Is this your doctor?
    Find A Second Opinion
    Not sure about your diagnosis?
    Check Your Symptoms
     
     
     
     
    Learn about our expert tiers
    Learn More
    Are you the provider on this profile?
    Claim Profile